Cargando…
Direct‐to‐consumer genetic testing for factor V Leiden and prothrombin 20210G>A: the consumer experience
BACKGROUND: Clinical genetic testing for inherited predisposition to venous thromboembolism (VTE) is common among patients and their families. However, there is incomplete consensus about which individuals should receive testing, and the relative risks and benefits. METHODS: We assessed outcomes of...
Autores principales: | Elson, Sarah L., Furlotte, Nicholas A., Hromatka, Bethann S., Wilson, Catherine H., Mountain, Joanna L., Rowbotham, Helen M., Varga, Elizabeth A., Francke, Uta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667316/ https://www.ncbi.nlm.nih.gov/pubmed/32940023 http://dx.doi.org/10.1002/mgg3.1468 |
Ejemplares similares
-
Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome
por: Padda, Jaskamal, et al.
Publicado: (2021) -
Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients
por: Akın, Dilara Fatma, et al.
Publicado: (2012) -
Acute Myocardial Infarction in Patients with Hereditary Thrombophilia—A Focus on Factor V Leiden and Prothrombin G20210A
por: Badescu, Minerva Codruta, et al.
Publicado: (2023) -
The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism
por: Machado, Marcia, et al.
Publicado: (2023) -
Factor V Leiden G1691A and prothrombin G20210A mutations among Palestinian patients with sickle cell disease
por: Samarah, Fekri, et al.
Publicado: (2018)